Search for: "Boehringer-Ingelheim"
Results 81 - 100
of 443
Sort by Relevance
|
Sort by Date
2 Jan 2017, 12:00 pm
Now, the PRAC's review will include the other SGLT2 inhibitor medicines dapagliflozin (Farxiga, Xigduo XR, AstraZeneca), and empagliflozin (Jardiance, Boehringer Ingelheim), based on the determination that the potential risk may be relevant for them as well. [read post]
30 Dec 2016, 2:58 pm
Permission to appeal in patent cases - farewell to the Pozzoli approachGuest Kat Eibhlin Vardy recaps the case Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, [2016] EWCA Civ 1296. [read post]
21 Dec 2016, 12:48 am
These are the issues considered by the Court of Appeal in last week's decision concerning an application for permission to appeal in Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG [2016] EWCA Civ 1296. [read post]
15 Dec 2016, 11:20 am
Ashtyn Evans, analyst with the Edward Jones investment company, expects annual Jardiance sales to approach $4 billion by the early 2020s, up from $200 million now, split with privately held German partner Boehringer Ingelheim. [read post]
18 Nov 2016, 11:38 am
In May of 2014 alone, Boehringer Ingelheim, the German manufacturer of Pradaxa, settled more than 4,000 lawsuits for a combined amount of $650 million. [read post]
18 Nov 2016, 11:38 am
In May of 2014 alone, Boehringer Ingelheim, the German manufacturer of Pradaxa, settled more than 4,000 lawsuits for a combined amount of $650 million. [read post]
15 Nov 2016, 2:00 pm
Boehringer Ingelheim GMBH, 237F.3d 1359, 1365 (Fed. [read post]
28 Sep 2016, 10:03 am
" In advance of the tomorrow's meeting, numerous organizations have written to the Council as follows:Letter from Business Europe - click hereLetter from UJUB - click hereLetter sent by Michel Guilbaud (DG MEDEF) to Philippe Léglise-Costa, Secretary General of SGAE - click hereLetter by several companies (including Air Liquide, Boehringer Ingelheim, Bayer, Audi, Bosch, SAP and VW) to Mr Kris Peeters (Deputy Prime Minister, Belgium) - click here A… [read post]
17 Sep 2016, 7:08 am
Specifically, the decision is being lauded by Boehringer Ingelheim, the makers of Pradaxa, according to a recent news feature from FiercePharma. [read post]
17 Sep 2016, 7:08 am
Specifically, the decision is being lauded by Boehringer Ingelheim, the makers of Pradaxa, according to a recent news feature from FiercePharma. [read post]
22 Aug 2016, 1:05 pm
About Pradaxa Pradaxa, also known as Dabigatran, is manufactured by Boehringer Ingelheim Pharmaceuticals and is prescribed to help prevent the blood from coagulating or clotting. [read post]
10 Aug 2016, 1:27 pm
The drug was produced by German manufacturer Boehringer Ingelheim Pharmaceuticals as a substitute to the drug warfarin. [read post]
10 Aug 2016, 1:27 pm
The drug was produced by German manufacturer Boehringer Ingelheim Pharmaceuticals as a substitute to the drug warfarin. [read post]
5 Aug 2016, 2:10 pm
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention (Posted by Tom Lamb at DrugInjuryWatch.com) This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors Class of… [read post]
13 Jul 2016, 1:56 pm
About a month later, however, only those three diabetes drugs from Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
30 Jun 2016, 12:12 pm
“For dabigatran [Pradaxa, Boehringer Ingelheim]-treated patients, idarucizumab [Praxbind, Boehringer Ingelheim], a monoclonal antibody that binds dabigatran and acutely reverses its anticoagulation effect, is currently approved for major bleeding or for patients requiring emergency procedures, and is available in many countries,” Levy and Hunt wrote. [read post]
3 Jun 2016, 10:50 am
“Boehringer Ingelheim to Settle 4,000 Pradaxa Lawsuits for $650 Million. [read post]
8 May 2016, 9:59 pm
KG; Boehringer Ingelheim International GmbH; Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
31 Mar 2016, 6:40 am
" Dr Peters, who also writes a column for Medscape Diabetes & Endocrinology, has served as a speaker or consultant with Eli Lilly, Boehringer Ingelheim Pharmaceuticals, and AstraZeneca Pharmaceuticals, which make SGLT-2 inhibitors. [read post]
5 Mar 2016, 7:01 am
However, Boehringer Ingelheim, the maker of Pradaxa, has also created the antidote they are marketing as Praxbind. [read post]
